{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:22:48Z","timestamp":1762323768882},"reference-count":22,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Robust epidemiological information on hepatitis B is important to help countries plan prevention and control programmes and evaluate public health responses to control transmission. European Centre Disease Prevention and Control (ECDC) introduced enhanced surveillance of hepatitis B at EU\/EEA level in 2011 to collate routine surveillance data from national notification systems. Analysis of the data collected for the years 2006\u20132012 shows a high burden of hepatitis B across Europe with 110\u00a0005 cases reported over the period with the majority of these cases being chronic infections. The most commonly reported routes of transmission in acute cases included heterosexual transmission, nosocomial transmission, injecting drug use and transmission among men who have sex with men. Mother\u2010to\u2010child transmission was the most common route reported for chronic cases. Trends over time were difficult to analyse as national reporting practices changed, but data suggest a downward trend in acute cases, which probably reflects the impact of the widespread implementation of vaccination programmes. Notifications of chronic infection varied across countries and showed discrepancy with the expected results based on findings from recent prevalence surveys. This indicated that notifications mirror local testing practices rather than real occurrence of disease. Improving the quality of the data and considering reported notifications alongside other data sources, such as local screening practices and vaccination policies, will improve the utility of the data.<\/jats:p>","DOI":"10.1111\/jvh.12364","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T06:10:38Z","timestamp":1416809438000},"page":"581-589","source":"Crossref","is-referenced-by-count":19,"title":["Enhanced surveillance of hepatitis <scp>B<\/scp> in the <scp>EU<\/scp>, 2006\u20132012"],"prefix":"10.1111","volume":"22","author":[{"given":"E. F.","family":"Duffell","sequence":"first","affiliation":[{"name":"European Centre for Disease Prevention and Control (ECDC) Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J. W.","family":"van de Laar","sequence":"additional","affiliation":[{"name":"Formerly of European Centre for Disease Prevention and Control (ECDC) Stockholm 171 83 Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Amato\u2010Gauci","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control (ECDC) Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-915644"},{"key":"e_1_2_8_3_1","first-page":"255","article-title":"Hepatitis B vaccines","volume":"79","author":"World Health Organisation","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00487.x"},{"key":"e_1_2_8_5_1","volume-title":"Annual Epidemiological Report on Communicable Diseases in Europe, 2009","author":"European Centre for Disease Prevention and Control","year":"2009"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00141-7"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2009.11.009"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00415-0"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj009"},{"key":"e_1_2_8_10_1","volume-title":"Surveillance and Prevention of Hepatitis B and C in Europe","author":"European Centre for Disease Prevention and Control","year":"2010"},{"issue":"21","key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"18880","DOI":"10.2807\/ese.13.21.18880-en","article-title":"Surveillance and epidemiology of hepatitis B and C in Europe \u2013 a review","volume":"13","author":"Rantala M","year":"2008","journal-title":"Euro Surveill"},{"key":"e_1_2_8_12_1","unstructured":"2012\/506\/EU:Commission Implementing Decision of 8 August 2012 Amending Decision 2002\/253\/EC Laying Down Case Definitions for Reporting Communicable Diseases to the Community Network Under Decision No 2119\/98\/EC of the European Parliament and of the Council (notified under document C(2012) 5538)."},{"key":"e_1_2_8_13_1","volume-title":"Hepatitis B and C in Europe, 2006\u20132011","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"e_1_2_8_14_1","volume-title":"Hepatitis B and C in Europe, 2012","author":"European Centre for Disease Prevention and Control","year":"2014"},{"key":"e_1_2_8_15_1","unstructured":"BrouardC.Hepatitis B and C Screening in France in 2010. The LaboHep 2010 Study Bull \u00c9pid\u00e9miol Hebd.2013. Available at:http:\/\/www.invs.sante.fr\/fr..\/Publications-et-outils\/BEH-Bulletin-epidemiologique-hebdomadaire\/Archives\/2013\/BEH-n-19-2013(accessed 21 May 2014)."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05600.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.7133"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-181"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.005"},{"key":"e_1_2_8_20_1","volume-title":"Hepatitis B and C in EU Neighbourhood","author":"European Centre for Disease Prevention and Control","year":"2010"},{"key":"e_1_2_8_21_1","unstructured":"The Health Protection Surveillance Centre European Centre for Disease Control VENICE II Project.Hepatitis B Vaccination in Europe November 2008\u2013March 2009. Available at:http:\/\/venice.cineca.org\/Report_Hepatitis_B_Vaccination.pdf(accessed 06 May 2014)."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cks067"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12364","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12364","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.12364","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T20:07:09Z","timestamp":1696277229000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1111\/jvh.12364"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12364","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,24]]}}}